- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Non-familial hypercholesterolaemia; Familial heterozygous hypercholesterolaemia; Familial homozygous hypercholesterolaemia
- Meeting Date: July 2026
Evolocumab – July 2026
- Injection 140 mg in 1 mL single use pre-filled pen
Public Summary Documents
Last updated
13 November 2026
